by Stemedix | Oct 30, 2023 | COPD, Regenerative Medicine, Stem Cell Research, Stem Cell Therapy
Chronic obstructive pulmonary disease (COPD) is a condition that affects about 12.5 million people in the United States. COPD can become progressively worse over time and affect your breathing.
Although lifestyle changes, oxygen therapy, and medications have traditionally served as the standard treatment choices, there is now another promising option for treating COPD, regenerative medicine, also known as stem cell therapy.
Understanding COPD: Symptoms and Causes
COPD is the umbrella term for several conditions that cause airflow blockages and other breathing-related issues. Chronic bronchitis and emphysema can both lead to COPD. Chronic bronchitis is the inflammation of your bronchial tubes’ lining, while emphysema destroys the air sacs at the ends of the smallest air passages.
Key Symptoms of COPD
Common symptoms of COPD are:
- Chest tightness
- Wheezing
- Fatigue
- Unintended weight loss
- Shortness of breath
- Chronic cough that produces clear, white, yellow, or green mucus
- Swelling in feet and ankles
It’s common to experience exacerbations, which is when symptoms get significantly worse for days at a time. Many factors cause exacerbations, including exposure to air pollution, respiratory infections, and anything else that triggers inflammation.
Causes and Risk Factors
Those most likely to develop COPD are women and people who:
- Are over 65.
- Have experienced air pollution.
- Had many respiratory infections during childhood.
One of the most prevalent causes of COPD is smoking. Smoking irritates your airways, triggering inflammation that narrows those airways. Because smoke also damages the cilia, they’re not able to effectively get rid of mucus or particles from the airways.
Another cause of COPD is alpha-1 antitrypsin (AAT) deficiency. This is an uncommon disorder that can cause emphysema. When you have AAT deficiency, you don’t have an enzyme that protects your lungs from inflammation. The deficiency makes it easier for your lungs to experience damage from irritating substances like dust and smoke.
The Current Treatments and Their Limitations
Current COPD treatments include the use of bronchodilators and steroids — as well as oxygen therapy — to minimize the symptoms of the condition.
Bronchodilators are medications that relax the muscles around the airways, helping you get better airflow. Some bronchodilators offer quick relief for acute episodes, while others are more appropriate for maintenance.
Steroids work together with bronchodilators to reduce airway inflammation. The problem with steroids is that they have significant side effects when used as a long-term treatment. Some of these side effects include weight gain, an increased risk of developing infections, and even bone loss.
Oxygen therapy is appropriate for people who have severe hypoxemia because it helps improve oxygen levels and relieve symptoms. Pulmonary rehabilitation programs are other options that combine exercise training with education to help patients understand the condition better.
Surgery is the last recourse for people with severe COPD who don’t find any relief from medications or other options. For some people, a lung transplant is a viable choice. For others, the removal of damaged lung tissue can offer some relief from symptoms.
Limitations of Traditional Treatments
Although doctors have been providing these options for a long time, they have limitations. For instance, they may offer relief from symptoms, but they typically don’t address the underlying cause of the problem. Even after treatment, the damage to your airway passages and lungs remains.
The side effects of long-term use of these treatments can also be serious. Corticosteroids put a strain on your heart, cause muscle weakness, and can even impact wound healing, which can make them a challenging choice for long-term management of COPD.
More invasive procedures, like surgery, have significant risks. Additionally, there are limits to who can receive surgery for COPD because of the use of anesthesia.
Recent Advances in the Treatment of COPD
To help improve the quality of life of a patient with COPD, new treatment options are available. By working closely with your doctor, you can find the right choice for your unique needs.
Drug Therapy Innovations
The latest medications for those with COPD are new bronchodilators and anti-inflammatory medications that don’t cause the same side effects that may make you hesitate to try long-term drug treatments. The goal of these new medications is to offer longer-lasting support and reduce the flares you experience with COPD.
Inhaler Technologies
Your inhaler is an important part of a COPD treatment program, and the latest technologies allow for better drug delivery while also ensuring that the inhaling techniques are correct. All of this makes it easier to stick to using your inhaler regularly.
Stem Cell Therapy for COPD
A new potential treatment option for COPD is regenerative medicine, also known as stem cell therapy. This type of regenerative medicine uses stem cells to help your body heal itself so that it can regenerate damaged tissue for better lung function.
Mesenchymal stem cells (MSCs) can be isolated from various sources, such as bone marrow, adipose tissue, or umbilical cord blood. These cells have the ability to differentiate into different cell types and possess immunomodulatory and regenerative properties.
MSCs have shown promise as a potential therapeutic approach for chronic obstructive pulmonary disease (COPD). While there is currently no cure for COPD, MSC-based therapies have the potential to modulate the immune response, reduce inflammation, and promote tissue repair in the lungs.
When administered into the lungs, MSCs can release anti-inflammatory molecules, promote tissue regeneration, and interact with the immune system to suppress excessive inflammation.
Getting Treatment for COPD
If you have COPD, ensuring that you have the right treatment plan on your side is vital for your long-term recovery. If you have COPD and it is progressively worsening, and there are limited treatment options available, you may want to explore stem cell therapy as a potential avenue for slowing disease progression or improving lung function.
Regenerative medicine aims to enhance what your body already does naturally, helping it heal so that you improve your quality of life. Speak to a regenerative specialist on the options you may have with this new alternative therapy option.
by admin | Oct 25, 2023 | Mesenchymal Stem Cells, Regenerative Medicine, Stem Cell Research, Stem Cell Therapy
Biomedical applications of mesenchymal stem cells (MSCs) in the field of regenerative medicine continue to evolve. Coupled with the rapid development of molecular biology and transplantation techniques, MSC applications have become a central focus of research surrounding regenerative medicine.
Since being discovered nearly 50 years ago, the understanding of various techniques for MSC extractions and the subsequent potential for differentiation has continued to advance.
This review, presented by Han et al., provides a brief overview of MSC extraction methods and their subsequent potential for differentiation and summarizes the future applications and challenges of various MSCs in the field of regenerative medicine.
It has now been well established that MSCs can be isolated from various tissues, including bone marrow, adipose, synovium, and human umbilical cord blood. The general process for MSC extraction involves the isolation of various tissues, digestion to obtain cells, culturing for three to five days, and continuous culturing of adherent cells to the desired passage.
Interestingly, the authors point out that rabbits are the most frequently used animal models for experiments involving cartilage or bone tissue regeneration. Considering this, the authors call for the surface markers of rabbit tissue-derived MSC to receive increased focus and further verification.
Han et al. also discuss the differentiation potentials of MSC types, highlighting that bone marrow-derived MSCs display superior capabilities for differentiation into osteogenesis and chondrogenesis under standard differentiation protocols. They also point out that umbilical cord blood-derived MSCs (UCB-MSCs) demonstrate biological advantages relative to other adult sources, including their capability for longer culture times, larger-scale expansion, and higher anti-inflammatory effects. Considering that differentiation conditions vary based on the type of MSC, the authors highlight that it is becoming increasingly necessary to choose the desired MSC type according to the specific purpose being sought.
MSC-based regenerative medicine has been widely studied and applied to many aspects of the field. This review summarizes several reports concerning the latest preclinical and clinical trials of various MSC types for tissue engineering, most notably the reconstruction of fragile tissue associated with the musculoskeletal system, nervous system, myocardium, liver, cornea, trachea, and skin.
In order to improve the therapeutic effectiveness of MSCs, while also reducing the potential identified risks, the authors suggest reducing excessive cytokines, further exploring the immunomodulatory effects of MSCs, and establishing strict preclinical biosafety testing rules. Additionally, longer and larger controlled clinical trials are required to further determine the safety of MSCs.
While there have been tremendous advances in the field of regenerative medicine, especially as they relate to MSCs, Han et al. share a number of challenges that have to be overcome before the clinical application of MSC therapy, with the primary challenge being the implementation of a standardized method of isolation and culturing for MSCs.
The authors conclude this review by summarizing three distinct properties of MSCs that make them an optimal source of tissue regeneration: their immunoregulatory capacity, paracrine or autocrine functions that generate growth factors, and their ability to differentiate into target cells.
Source: “Mesenchymal Stem Cells for Regenerative Medicine – PMC – NCBI.” 13 Aug. 2019, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721852/.
by admin | Sep 13, 2023 | Mesenchymal Stem Cells, Regenerative Medicine, Stem Cell Research, Stem Cell Therapy
Liver disease accounts for nearly two million deaths annually and is responsible for 4% of all deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related deaths occur in men.
Most forms of chronic liver disease result from viral infections, alcohol abuse, or metabolic disorders and eventually result in cirrhosis and liver failure. The only effective treatment for end-stage cirrhosis is liver transplantation. Unfortunately, considering organ shortages and the high cost associated with this type of medical procedure, liver transplants are not available in many countries.
Stem cell transplantation, specifically transplantation using mesenchymal stem cells (MSCs), has been increasingly used as a potential treatment strategy for a host of diseases, including for treating chronic liver disease.
As part of this review, Kang et al. discuss the therapeutic effects of MSCs in liver diseases to address questions regarding their efficacy and safety, evaluate recent advances in this area, and consider the potential risks and challenges in the use of MSC-based therapies for liver disease.
When considering the therapeutic effects of MSC therapy in chronic liver disease, the authors conclude that this treatment has shown to be effective, primarily due to their immunomodulation, differentiation, and antifibrotic properties exhibited by MSCs. The authors also point out that although the safety and therapeutic effects of MSC therapy have been observed in several clinical studies, to date the therapy has demonstrated only modest improvements in treating liver disease. Kang et al. attribute this modest improvement, in part, to the current limited feasibility of transplanted cells.
The authors provide a detailed review of the strategies that have been utilized to improve the effects of MSC transplantation, including tissue engineering, preconditioning, genetic engineering, and using extracellular vesicles as cell-free therapy, and summarize the future potential of each of these as ways to improve MSC transplantation.
Kang et al. also highlight several problems that must be considered and addressed before MSCs are fully accepted as clinical therapeutic treatment options for chronic liver disease; these problems include the potential for carcinogenesis and viral transmission. For example, previous animal studies have demonstrated a relationship between the development of sarcoma and the number of passages. While this has not been directly observed in clinical trials involving human MSCs, the follow-up period was too short to allow for observed evidence of this development. As a result, the authors call for a detailed study into the chromosomal integrity before MSC transplantation to ensure the safety of the procedure.
In addition to the potential for tumor cell growth, allotransplantation of MSC cells may involve the risk of viral transmission to the patients. As a result, the authors indicate that both MSC recipients and donors may need to be screened for the presence of specific viruses, including parvovirus B19, herpes simplex virus, and cytomegalovirus.
The authors conclude that the prospects of MSC-based cell therapy for treating chronic liver disease will be determined by standardizing the cell source, culture conditions, administration route, and the outcomes of future large-scale clinical trials.
Source: “Mesenchymal Stem Cells for the Treatment of Liver Disease – NCBI.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234888/.
by admin | Sep 6, 2023 | Multiple Sclerosis, Mesenchymal Stem Cells, Regenerative Medicine, Stem Cell Research, Stem Cell Therapy
Multiple sclerosis (MS) is a progressive auto-immune disease that affects the central nervous system (CNS). Currently, it is estimated that nearly 2 million people worldwide are affected by MS.
Characterized by the body attacking the myelin (the protective sheath that covers the nerve fibers), MS causes communication issues between the brain and the rest of the body. As the nerves continue to deteriorate, the condition can cause permanent damage.
Currently, there is no pharmaceutical treatment for MS, only medications that treat the symptoms of the condition.
In the field of regenerative medicine, mesenchymal stem cells (MSCs) have emerged as a candidate that could potentially treat a number of diseases, including MS. Specifically, MSCs have anti-inflammatory effects and have demonstrated the ability to differentiate in order to target the overactivity and self-antigen attacks observed in the development and progression of MS.
As part of this review, Alanazi et al. reviewed a number of clinical trials that have utilized MSCs isolated from a variety of sources, including peripheral blood, bone marrow (BM-MSCs), adipose tissue (AD-MSCs), umbilical cord (UCMSCs), and the placenta, in order to better understand their potential as a treatment option for MS.
An analysis of these clinical trials led the authors of this review to the consensus that MSCs appear effective in inhibiting CD4+ and CD8+ T cell activation, T regulatory cells, and macrophage switch into the auto-immune phenotype.
Further analysis of the specific MSCs used to treat MS by Alanazi et al. indicates that while BM-MSCs, AD-MSCs, and UCMSCs all demonstrate beneficial effects when applied to the treatment of MS, UCMSCs appear to be the best option.
According to the authors, UCMSCs demonstrate faster self-renewal than other MSCs, are able to differentiate into three germ layers, and can accumulate in damaged tissue or inflamed areas. Additionally, UCMSCs are also among the easiest MSCs to source, demonstrate a high concentration of MSCs, are safe and inexpensive, and are not associated with ethical issues.
Based on the information reviewed, Alanazi et al. recommend emphasizing the clinical utility of UCMSCs for regenerative medicine and immunotherapy, including for the treatment of MS.
Source: “Mesenchymal stem cell therapy: A review of clinical trials for multiple ….” 23 Aug. 2022, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420954/.
by admin | Aug 2, 2023 | Mesenchymal Stem Cells, Regenerative Medicine, Stem Cell Therapy
Because of its ability to simultaneously activate multiple mechanisms, including paracrine, trophic, immunomodulatory, and differentiation, researchers consider mesenchymal stem cells to be an effective option for stem cell therapy.
After years of active research, bone marrow-derived MSCs (BM-MSCs) have been a prevalent source for MSC-based studies. There is also active research using MSCs from a variety of other sources, including adipose tissue, peripheral and umbilical cord blood, amniotic fluid, skin, dental pulp, synovium, umbilical cord tissue, placental complex, and endometrium.
As part of this review, Arutyunyan et al. review umbilical cord-derived MSCs (UC-MSCs) as a prospective source for MSC-based therapy. More specifically, the authors focus on the potential therapeutic benefits of Wharton’s jelly, the gelatinous substance found in the umbilical cord stroma; of particular interest to researchers is the presence of mesenchymal-derived cells, including stem cells, with the absence of capillaries.
When studied in vitro, researchers found UC-MSCs demonstrated the ability to differentiate into a wide range of cells, including chondrocytes, adipocytes, osteoblasts, odontoblast-like cells, dermal fibroblasts, smooth muscle cells, and somatostatin-producing cells, sweat gland cells, endothelial cells, neuroglia cells, and dopaminergic neurons.
While it’s well known that MSCs produce a variety of bioactive compounds that supply a paracrine mechanism for their therapeutic activity, researchers have learned that UC-MSCs secretomes differ significantly from MSCs from bone marrow and adipose. Specifically, the most significant difference is UC-MSCs’ nearly complete absence of synthesis of the main proangiogenic factor, VEGF-A. UC-MSCs also demonstrate increased production of antiangiogenic factors when compared to BM-MSCs and AT-MSCs.
UC-MSCs have recently demonstrated the ability to transfer their own mitochondria into mitochondrial DNA-depleted cells. This observation has broad implications for the therapeutic potential of UC-MSCs, primarily due to the failure of mitochondria as an initial event in many diseases. In this regard, the authors conclude that the transfer of mitochondria provides a rationale for the therapeutic use of UC-MSCs for ischemic injury or disease linked to mitochondrial dysfunction.
Arutyunyan et al. found recent animal model preclinical studies regarding the use of UC-MSCs for the treatment of different diseases demonstrated promising results. Additionally, clinical studies involving UC-MSCs demonstrated to be safe with no significant side effects other than fever.
While the authors point out concern with the lack of standardized protocols for the isolation and expansion of UC-MSCs and of uniform requirements for the final product. Despite these concerns, the authors also conclude that the results of clinical trials using UC-MSCs are encouraging, particularly for the treatment of autoimmune and endocrine diseases.
Source: “Umbilical Cord as Prospective Source for Mesenchymal Stem Cell ….” 29 Aug. 2016, https://www.hindawi.com/journals/sci/2016/6901286/.
by Stemedix | Jul 31, 2023 | Mesenchymal Stem Cells, Parkinson's Disease, Regenerative Medicine, Stem Cell Therapy
What is Post Stroke and How is it Diagnosed?
“Post-stroke” or “post-stroke period” refers to the period of time following a stroke. A stroke occurs when there is a sudden disruption of blood flow to a part of the brain, leading to brain cell damage and, potentially, the death of brain tissue. The severity and specific consequences of a stroke depend on various factors, such as the type of stroke (ischemic or hemorrhagic) and the location and size of the affected brain area.
The post-stroke period is a critical time for stroke survivors as they begin their recovery and rehabilitation journey. During this period, individuals may experience a range of physical, cognitive, emotional, and social challenges. The post-stroke phase can vary in duration and intensity depending on the extent of brain damage and the effectiveness of treatment and rehabilitation.
Some common aspects and challenges of the post-stroke period include:
Medical stabilization: In the immediate aftermath of a stroke, medical professionals focus on stabilizing the patient, preventing further damage, and addressing any potential complications.
Acute care and rehabilitation: Once the individual’s condition is stable, they may undergo rehabilitation, which may involve physical therapy, occupational therapy, speech therapy, and other specialized treatments to help restore lost functions and improve independence.
Physical recovery: Many stroke survivors experience weakness, paralysis, or difficulty with mobility. Physical therapy aims to help them regain strength, balance, and coordination.
Cognitive recovery: Depending on the area of the brain affected, stroke survivors may experience difficulties with memory, attention, language, and problem-solving. Cognitive rehabilitation can assist in addressing these issues.
Emotional and psychological support: Stroke can have significant emotional and psychological impacts. Depression, anxiety, and frustration are not uncommon during the post-stroke period.
Social reintegration: Stroke survivors may face challenges in reintegrating into their communities and resuming their daily activities. Support from family, friends, and support groups can be essential during this phase.
Long-term management: For some individuals, the effects of a stroke may be permanent, necessitating ongoing care and management of any residual disabilities or health issues.
The post-stroke period is highly individual, and recovery outcomes can vary widely from person to person. Early intervention, rehabilitation, and ongoing support play vital roles in improving the quality of life for stroke survivors.
Diagnosing a stroke typically involves a combination of clinical evaluation, medical history assessment, and imaging tests. Rapid and accurate diagnosis is crucial because time is of the essence when it comes to stroke treatment.
The faster a stroke is diagnosed and treated, the better the chances of minimizing brain damage and improving outcomes.
What Are The Different Types of Stroke?
There are two main types of strokes: ischemic stroke and hemorrhagic stroke. Each type has different underlying causes:
Ischemic Stroke:
Ischemic strokes account for about 85% of all strokes and occur when there is a blockage or narrowing of a blood vessel supplying blood to the brain. This blockage can be due to a blood clot (thrombus) that forms within a blood vessel in the brain (cerebral thrombosis) or elsewhere in the body and travels to the brain (cerebral embolism).
Common risk factors for ischemic stroke include atherosclerosis (the buildup of fatty deposits in the blood vessels), high blood pressure (hypertension), diabetes, high cholesterol levels, smoking, and certain heart conditions such as atrial fibrillation.
Hemorrhagic Stroke:
Hemorrhagic strokes occur when a blood vessel in the brain ruptures, causing bleeding into or around the brain tissue. The bleeding puts pressure on brain cells and can damage them.
The two main types of hemorrhagic stroke are intracerebral hemorrhage (bleeding within the brain) and subarachnoid hemorrhage (bleeding into the space between the brain and the thin tissues that cover it).
Hypertension is a significant risk factor for hemorrhagic stroke, as it can weaken blood vessel walls over time. Other risk factors include brain aneurysms, arteriovenous malformations (AVMs), and certain blood-thinning medications.
How Can I Avoid a Potential Stroke?
It’s important to note that certain lifestyle factors and medical conditions can increase the risk of stroke. These include:
- Sedentary lifestyle
- Poor diet (high in saturated fats, salt, and processed foods)
- Obesity
- Excessive alcohol consumption
- Illicit drug use, especially cocaine and amphetamines
- Heart disease
- Family history of stroke or cardiovascular disease
- Age (stroke risk increases with age)
- Gender (men have a slightly higher risk)
- Race and ethnicity (some groups, such as African Americans and Hispanics, have higher stroke risk)
Managing risk factors through lifestyle changes and medical treatment can significantly reduce the likelihood of experiencing a stroke.
How Do You Know If You Are Having or Have Had a Stroke?
If you suspect someone is having a stroke or experience symptoms yourself, it’s crucial to seek immediate medical attention as prompt treatment can minimize brain damage and improve outcomes. Remember, “FAST” is a simple way to remember the most common symptoms of a stroke:
F – Face drooping
A – Arm weakness
S – Speech difficulty
T – Time to call emergency services.
Recognizing the symptoms of a stroke is crucial because immediate medical attention can greatly improve the chances of minimizing brain damage and improving outcomes. The symptoms of a stroke can vary depending on the type of stroke (ischemic or hemorrhagic) and the part of the brain affected.
Here are some common signs and symptoms of a stroke:
Sudden numbness or weakness: You may experience sudden numbness or weakness in the face, arm, or leg, typically affecting one side of the body. A common indicator is drooping on one side of the face when trying to smile.
Trouble speaking or understanding speech: You might have difficulty speaking coherently or understanding what others are saying. Your speech may become slurred or difficult to comprehend.
Confusion or trouble with comprehension: You may feel confused, disoriented, or have difficulty understanding simple instructions or questions.
Sudden severe headache: A sudden, severe headache that is different from any previous headaches you’ve experienced may be a warning sign of a stroke, especially if it’s accompanied by other symptoms.
Trouble with vision: You may experience sudden blurred or double vision or have trouble seeing out of one or both eyes.
Dizziness or loss of balance: You may feel dizzy, lightheaded, or have trouble maintaining your balance, leading to difficulty walking or coordination problems.
hemorrhagic strokes) to prevent further damage to the brain. Rehabilitation and support following a stroke are also essential for recovery and regaining function.
What Treatments Are There for Post Stroke Care?
Post-stroke care focuses on the rehabilitation and management of stroke survivors to improve their physical, cognitive, emotional, and social functioning. The specific treatments for post-stroke care depend on the individual’s needs and the extent of the stroke’s impact. Here are some common components of post-stroke care and treatments:
- Physical therapy
- Occupational therapy
- Speech therapy
- Cognitive rehabilitation
- Emotional support and counseling
- Medications
- Pain management
- Assistive devices
- Nutritional support
- Social and vocational support
Post-stroke care is often a multidisciplinary approach, involving a team of healthcare professionals working together to develop a personalized treatment plan. The goal is to maximize the individual’s functional recovery, promote independence, and enhance their overall quality of life after a stroke. As each stroke survivor’s situation is unique, the treatment plan will be tailored to their specific needs and abilities. Regular follow-up appointments and ongoing support are essential components of post-stroke care to monitor progress and adjust treatment as necessary.
Regenerative Medicine for Post Stroke Management
Regenerative medicine, also known as stem cell therapy, is a cutting-edge field of medicine that focuses on harnessing the regenerative capabilities of stem cells to treat various medical conditions and injuries, including post-stroke care.
Mesenchymal stem cells (MSCs) are unique cells that have the ability to differentiate into different cell types and self-renew, meaning they can produce more stem cells. MSCs are a type of adult stem cell found in various tissues, such as bone marrow and adipose (fat) tissue. They have the unique ability to differentiate into different cell types and secrete bioactive molecules that can promote tissue repair and modulate the immune response.
In the context of post-stroke care, MSC therapy aims to harness the regenerative and immunomodulatory properties of these stem cells to potentially enhance neurological recovery and reduce post-stroke complications.
Several preclinical studies and early-phase clinical trials have investigated the safety and potential benefits of MSC therapy for stroke. Here are some potential ways MSCs might exert beneficial effects in post-stroke patients:
- Neuroprotection: MSCs have been shown to secrete factors that protect neurons from further damage and promote cell survival in animal models of stroke.
- Anti-inflammatory effects: After a stroke, inflammation in the brain can exacerbate damage. MSCs can modulate the immune response, reducing harmful inflammation and promoting a more favorable environment for recovery.
- Angiogenesis: MSCs can support the formation of new blood vessels (angiogenesis) in damaged brain tissue, improving blood flow and oxygen supply to the affected areas.
- Neuroplasticity: MSCs may help enhance brain plasticity, which is the brain’s ability to reorganize and form new neural connections, potentially aiding recovery and functional improvements.
If you or someone you know is interested in exploring this alternative medicine, work with a regenerative medicine specialist who can help provide detailed information about the options available to them.
St. Petersburg, Florida
